Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05360732
What this trial is testing

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Fox Chase Cancer Center 37
Post-approval studies (Phase 4)Study completedNCT01932125
What this trial is testing

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02889523
What this trial is testing

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

Who this might be right for
LymphomaDLBCLFollicular Lymphoma
The Lymphoma Academic Research Organisation 214
Testing effectiveness (Phase 2)Study completedNCT01191892
What this trial is testing

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more
Cardiff University 82
Testing effectiveness (Phase 2)UnknownNCT06341530
What this trial is testing

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Zhengzhou University 33
Not applicableWithdrawnNCT04694560
What this trial is testing

A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
CLLSLLCLL/SLL+2 more
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04368884
What this trial is testing

Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients

Who this might be right for
Covid-19
Max Healthcare Insititute Limited 1,000
Testing effectiveness (Phase 2)Study completedNCT01025505
What this trial is testing

Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Who this might be right for
TreatmentStem Cell Transplantation
Gruppo Italiano Malattie EMatologiche dell'Adulto 40
Testing effectiveness (Phase 2)Study completedNCT00358644
What this trial is testing

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Eisai Inc. 55
Testing effectiveness (Phase 2)Looking for participantsNCT07423585
What this trial is testing

Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
Asrar Alahmadi 39
Testing effectiveness (Phase 2)UnknownNCT01971281
What this trial is testing

Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Who this might be right for
Pancreatic Adenocarcinoma
NovoCure Ltd. 40
Large-scale testing (Phase 3)Study completedNCT00190489
What this trial is testing

A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Japan Clinical Oncology Group 450
Early research (Phase 1)Study completedNCT05557643
What this trial is testing

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout

Who this might be right for
DepressionBurnout, Professional
University of Utah 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647732
What this trial is testing

Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT)

Who this might be right for
Mucosa-associated Lymphoid Tissue Lymphoma (MALT)
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Looking for participantsNCT06965114
What this trial is testing

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

Who this might be right for
Hairy Cell LeukemiaRecurrent Hairy Cell LeukemiaRefractory Hairy Cell Leukemia
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)UnknownNCT00628238
What this trial is testing

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaCLLUntreated+3 more
Chronic Lymphocytic Leukemia Research Consortium 80
Testing effectiveness (Phase 2)Study completedNCT03326193
What this trial is testing

Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 105
Not applicableStudy completedNCT05812898
What this trial is testing

Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Cairo University 42
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Not applicableStudy completedNCT01026467
What this trial is testing

Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Wake Forest University Health Sciences 45
Next Page